Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast
Abstract
Gross cystic disease fluid protein‐15 (GCDFP‐15) is a commonly used apocrine marker; however, its expression was recently found to decrease in infiltrating, larger, or metastasizing apocrine carcinomas of the breast. In the breast, monoclonal antibody (MAb) B72.3 has been reported to be useful as an apocrine marker although it is used for that purpose much less frequently than GCDFP‐15. In the search for a more consistent apocrine marker, immunoreactivity for MAb B72.3 was examined in apocrine carcinomas at different stages and compared with GCDFP‐15. 47 of 51 apocrine carcinomas (92%) and 9 of 62 ordinary carcinomas (15%) were MAb B72.3 positive, while 39 of 51 apocrine carcinomas (76%) and 13 of 62 ordinary carcinomas (21%) were GCDFP‐15 positive. Thus, both sensitivity and specificity were higher for MAb B72.3. Furthermore, unlike GCDFP‐15, MAb B72.3 exhibited positivity irrespective of infiltrating status, tumor size, or metastatic status. There was no correlation between MAb B72.3‐immunoreactivity and GCDFP‐15‐expression. The combined usage of MAb B72.3 with GCDFP‐15 was useful to confirm the diagnosis of apocrine carcinoma, especially for advanced tumors, with only two cases being negative for both MAb B72.3 and GCDFP‐15. Whether these two cases should be differentiated from ordinary apocrine carcinomas remains to be investigated.Keywords
This publication has 15 references indexed in Scilit:
- Expression of GCDFP‐15 and AR decreases in larger or node‐positive apocrine carcinomas of the breastHistopathology, 2005
- Breast carcinoma in women over the age of 85: distinct histological pattern and androgen, oestrogen, and progesterone receptor statusHistopathology, 2003
- Oncocytic Carcinoma (Malignant Oncocytoma) of the BreastAmerican Journal of Surgical Pathology, 1998
- Androgen Receptor Expression Along with Loss of bcl-2, ER, and PR Expression in Benign and Malignant Apocrine Lesions of the Breast: Implications for TherapyThe Breast Journal, 1996
- bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancerBritish Journal of Cancer, 1994
- Secretion of breast gross cystic disease fluid proteins by T47D breast cancer cells in culture — modulation by steroid hormonesBreast Cancer Research and Treatment, 1992
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Immunohistochemical Staining with Monoclonal Ab B72.3 in Benign and Malignant Breast DiseaseAmerican Journal of Surgical Pathology, 1990
- Invasive apocrine carcinoma of the breast: A long term follow-up study of 34 casesBreast Cancer Research and Treatment, 1988
- Breast gross cystic disease protein 15 in human breast cancer in cultureEuropean Journal of Cancer and Clinical Oncology, 1988